Archive for: English

Diagonal Bio applies for change of marketplace to NGM Nordic SME

, , ,
Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") today announces that the Company – in order to be able to reallocate costs – has decided to apply for listing on NGM Nordic SME (“NGM”). The decision is based on…

Diagonal Bio AB’s announces last day of trading in BTU and first day of trading in warrants of series TO 2

, , ,
Diagonal Bio AB's ("Diagonal Bio" or the "Company") rights issue of units, with a subscription period ending on 6 February 2025, has now been registered at the Swedish Companies Registration Office together with the directed issue of units which…

Diagonal Bio AB resolves on a directed issue of units to all external underwriters

, , ,
The Board of Directors of Diagonal Bio AB ("Diagonal Bio" or the "Company") has today, based on the authorisation granted by the Extraordinary General Meeting on 17 January 2025 resolved on a directed issue of 2,587,768 units to underwriters…

Diagonal Bio’s CEO Karin Wehlin increases ownership

, ,
Diagonal Bio AB’s (”Diagonal Bio” or the ”Company”) CEO, Karin Wehlin, has directly and through Wehlin’s fully owned company WW Advise AB purchased 8,500,000 shares in the Company to a total price of approximately…

Diagonal Bio AB’s rights issue of units oversubscribed

, , , ,
The subscription period in Diagonal Bio AB’s ("Diagonal Bio" or the "Company") rights issue of units of initially approximately SEK 6.0 million ended on 6 February 2025 (the "Rights Issue"). The Rights Issue was subscribed to a total of…

Stall Goop conducts pilot test of LAMPlify®

, , , ,
Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") has signed an agreement with Stall Goop regarding a pilot test of LAMPlify®.  The three-month pilot test, starting in February 2025, aims to enhance equine health and performance…

Diagonal Bio announces positive pilot test results and secures order from StallZet

, , , ,
Diagonal Bio AB (publ) ("Diagonal Bio" or the "Company") announces an order valued at approximately SEK 150,000 from Daniel Redén, a renowned horse trainer at StallZet. The order comes as a result of the successful completion of…

The subscription period of Diagonal Bio AB’s rights issue of units commences today

, , ,
Today, 23 January 2025, the subscription period in Diagonal Bio AB’s ("Diagonal Bio" or the "Company") rights issue of units of initially approximately SEK 6 million, with preferential rights for the Company’s existing shareholders,…

Diagonal Bio AB publishes investment memorandum prior to upcoming rights issue of units

, , ,
The subscription period of Diagonal Bio AB’s ("Diagonal Bio" or the "Company") rights issue of units, which was resolved on 23 December 2024 by the Board of Directors together with the resolution on a directed issue of units, commences…

Nomination Committee change in Diagonal Bio (publ.)

, ,
Diagonal Bio announces a change the Nomination Committee for the Annual General Meeting (AGM) on May 20, 2025.According to the instructions for the Nomination Committee adopted by the AGM in 2024, the Nomination Committee for the Diagonal Bios…